MYOR Wins Top Prize at Annual Digital Health Conference

Israeli startup develops ground-breaking diagnostic platform for the prediction and prevention of Eczema in toddlers

By Terrance J. Mintner • January 10, 2020

Israeli startup MYOR wins top prize at annual Digital Health conference for its ground-breaking diagnostic platform for the prediction and prevention of atopic dermatitis (Eczema) in toddlers.

(Left) CEO of MYOR Idan Katz. Photo Credit: Niv Kantor and Elad Gutman | People and Computers

At Spectory we’ve been helping entrepreneurs devise life-changing technologies in the digital health sector, one predicted to grow by leaps and bounds in 2020 and beyond.

We’ve mastered a range of medical solutions for a variety of customers, including startups and major health institutes.

A few months back a company called MYOR came to us for help on designing and developing their decision support system for the prediction and prevention of atopic dermatitis (Eczema) in toddlers.

The prevalence of this chronic illness has tripled worldwide over the last quarter century. Doctors speculate the rapid increase is linked to environmental factors such as seasonality, climate, air pollution, as well as lifestyle choices such as frequent bathing and use of scented lotions, shampoos and soaps, which can dry out skin and affect its overall health.

Children suffering from the condition experience red and dry skin, frequent itching, and an overall dip in their immune system. They are often beset with serious allergic reactions directly linked to Eczema. What’s scary is that nobody has yet come up with a cure for it, which makes prevention even more vital.

The existing digital solutions for dealing with the illness are limited. They can only manage the condition and treat the symptoms, not offer predictions or a preventive care regiment.

Recognizing this gap, MYOR began to build a massive database involving millions of Eczema cases. With this huge trove of data it then developed a comprehensive diagnostic platform for preventive-care options. If used successfully and in time, the platform could spare children susceptible to the illness a lot of undue suffering. It would also save on the cost of future treatments.

“Our skin reflects our health and can be used as a window into the body, using biological markers associated with various health conditions,” MYOR’s CEO Idan Katz recently stated in an interview.

MYOR’s platform uses AI tools to produce data on a child’s skin condition, giving doctors a better sense of how susceptible he or she is to skin asthma and related food allergies, which often accompany atopic dermatitis.

Given the potential benefits of this breakthrough technology it’s understandable why MYOR was eager to showcase it. The annual dHealth2019 conference – held in northern Israel in mid-December of last year – was the perfect opportunity.

Our skin reflects our health and can be used as a window into the body

MYOR was under a strict deadline to get its product ready for the conference, a major event attended by hundreds of experts in health innovation as well as technology incubators and VC managers. Spectory was proud to have delivered it on time.

The conference included a competition for the most prominent startups in the field. We were overjoyed to see MYOR steadily climb to the top of the competition. It made the top five (out of 1,500 overall contestants) and then won the whole thing. Top prize!

This meant business support in the form of a sizeable cash injection and a chance to work with leading accelerators like IBM Alpha Zone and eHealth Ventures.

We congratulate MYOR on this stunning accomplishment. We wish the company the best of luck in the new decade and are thrilled to continue our innovative partnership.

More From the newsletter

Leave a Reply